RETRACTED: Synthesis and Biological Evaluation of Entecavir 4′-Ester Derivatives (Retracted article. See vol. 31, pg. 1078, 2015)

被引:3
|
作者
Feng Deri [1 ]
Liu Jiaan [1 ]
Liang Shuang [1 ]
Wang Yanyan [1 ]
Xu Youjun [1 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Shenyang 110016, Peoples R China
基金
中国国家自然科学基金;
关键词
Entecavir; Anti-HBV activity; Intestinal membrane permeability; HEPATITIS-B-VIRUS; PHARMACOKINETICS; INFECTION; PRODRUG; POTENT; ACID; LAMIVUDINE; TRIAL; DRUG;
D O I
10.1007/s40242-014-4183-y
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Entecavir can significantly inhibit the replication of HBV-DNA, reduce the HBV-DNA level in blood serum. But suffering from low oral bioavailability, entecavir has low intestinal membrane permeability and poor metabolic stability. In this study, 12 different derivatives of entecavir 4'-ester were regioselectively synthesized and their apical-to-basolateral permeabilities across Caco-2 cells and HBV-DNA inhibitory efficacies were evaluated. Most of the compounds showed high permeabilities across Caco-2 cells compared with entecavir, compounds 5b and 5e also exhibited comparable anti-BBV activities with that of entecavir, especially.
引用
收藏
页码:749 / 754
页数:6
相关论文
共 50 条